rs74982956

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001848.3(COL6A1):​c.1119+39C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00903 in 1,606,404 control chromosomes in the GnomAD database, including 899 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0085 ( 76 hom., cov: 33)
Exomes 𝑓: 0.0091 ( 823 hom. )

Consequence

COL6A1
NM_001848.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.33

Publications

1 publications found
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 21-45991080-C-T is Benign according to our data. Variant chr21-45991080-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 93806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A1NM_001848.3 linkc.1119+39C>T intron_variant Intron 15 of 34 ENST00000361866.8 NP_001839.2 P12109A0A384P5H7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkc.1119+39C>T intron_variant Intron 15 of 34 1 NM_001848.3 ENSP00000355180.3 P12109

Frequencies

GnomAD3 genomes
AF:
0.00852
AC:
1297
AN:
152184
Hom.:
76
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0128
Gnomad ASJ
AF:
0.00662
Gnomad EAS
AF:
0.147
Gnomad SAS
AF:
0.0429
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000735
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.0183
AC:
4525
AN:
247546
AF XY:
0.0185
show subpopulations
Gnomad AFR exome
AF:
0.000380
Gnomad AMR exome
AF:
0.0115
Gnomad ASJ exome
AF:
0.00542
Gnomad EAS exome
AF:
0.139
Gnomad FIN exome
AF:
0.00269
Gnomad NFE exome
AF:
0.00112
Gnomad OTH exome
AF:
0.0117
GnomAD4 exome
AF:
0.00909
AC:
13215
AN:
1454102
Hom.:
823
Cov.:
32
AF XY:
0.00991
AC XY:
7174
AN XY:
723736
show subpopulations
African (AFR)
AF:
0.000511
AC:
17
AN:
33286
American (AMR)
AF:
0.0116
AC:
520
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.00606
AC:
158
AN:
26090
East Asian (EAS)
AF:
0.182
AC:
7208
AN:
39660
South Asian (SAS)
AF:
0.0423
AC:
3646
AN:
86130
European-Finnish (FIN)
AF:
0.00279
AC:
146
AN:
52318
Middle Eastern (MID)
AF:
0.0104
AC:
60
AN:
5754
European-Non Finnish (NFE)
AF:
0.000702
AC:
777
AN:
1106056
Other (OTH)
AF:
0.0114
AC:
683
AN:
60160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
663
1326
1989
2652
3315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00850
AC:
1295
AN:
152302
Hom.:
76
Cov.:
33
AF XY:
0.0103
AC XY:
770
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41562
American (AMR)
AF:
0.0129
AC:
198
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00662
AC:
23
AN:
3472
East Asian (EAS)
AF:
0.146
AC:
756
AN:
5162
South Asian (SAS)
AF:
0.0427
AC:
206
AN:
4822
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000735
AC:
50
AN:
68036
Other (OTH)
AF:
0.00710
AC:
15
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
61
122
182
243
304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00315
Hom.:
2
Bravo
AF:
0.00905
Asia WGS
AF:
0.0690
AC:
238
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 05, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.9
DANN
Benign
0.68
PhyloP100
-3.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74982956; hg19: chr21-47410994; COSMIC: COSV62612161; COSMIC: COSV62612161; API